Global Isocitrate Dehydrogenase Inhibitors Market 2021 by Company, Regions, Type and Application, Forecast to 2026
The Isocitrate Dehydrogenase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Isocitrate Dehydrogenase Inhibitors size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Isocitrate Dehydrogenase Inhibitors market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Isocitrate Dehydrogenase Inhibitors market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
IDH1 Mutant Medullary Malignant Tumor
IDH2 Mutant Medullary Malignant Tumor
Others
Market segment by Application, can be divided into
DH Inhibitor
FLT3 Inhibitor
Hedgehog Pathway Inhibitor
Others
Market segment by players, this report covers
AGIOS
Aslan Pharmaceuticals
Bayer
Beigene
Bristol-Myers Squibb
Celgene
Daiichi Sankyo
Philogen S.p.A.
Tesaro
Tragara/Adastra
Tocagen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Isocitrate Dehydrogenase Inhibitors
1.2 Classification of Isocitrate Dehydrogenase Inhibitors by Type
1.2.1 Overview: Global Isocitrate Dehydrogenase Inhibitors Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type in 2020
1.2.3 IDH1 Mutant Medullary Malignant Tumor
1.2.4 IDH2 Mutant Medullary Malignant Tumor
1.2.5 Others
1.3 Global Isocitrate Dehydrogenase Inhibitors Market by Application
1.3.1 Overview: Global Isocitrate Dehydrogenase Inhibitors Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 DH Inhibitor
1.3.3 FLT3 Inhibitor
1.3.4 Hedgehog Pathway Inhibitor
1.3.5 Others
1.4 Global Isocitrate Dehydrogenase Inhibitors Market Size & Forecast
1.5 Global Isocitrate Dehydrogenase Inhibitors Market Size and Forecast by Region
1.5.1 Global Isocitrate Dehydrogenase Inhibitors Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Isocitrate Dehydrogenase Inhibitors Market Size by Region, (2016-2021)
1.5.3 North America Isocitrate Dehydrogenase Inhibitors Market Size and Prospect (2016-2026)
1.5.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size and Prospect (2016-2026)
1.5.6 South America Isocitrate Dehydrogenase Inhibitors Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Isocitrate Dehydrogenase Inhibitors Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Isocitrate Dehydrogenase Inhibitors Market Drivers
1.6.2 Isocitrate Dehydrogenase Inhibitors Market Restraints
1.6.3 Isocitrate Dehydrogenase Inhibitors Trends Analysis
2 Company Profiles
2.1 AGIOS
2.1.1 AGIOS Details
2.1.2 AGIOS Major Business
2.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.1.4 AGIOS Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 AGIOS Recent Developments and Future Plans
2.2 Aslan Pharmaceuticals
2.2.1 Aslan Pharmaceuticals Details
2.2.2 Aslan Pharmaceuticals Major Business
2.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.2.4 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Aslan Pharmaceuticals Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.3.4 Bayer Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Beigene
2.4.1 Beigene Details
2.4.2 Beigene Major Business
2.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.4.4 Beigene Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beigene Recent Developments and Future Plans
2.5 Bristol-Myers Squibb
2.5.1 Bristol-Myers Squibb Details
2.5.2 Bristol-Myers Squibb Major Business
2.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.5.4 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.6 Celgene
2.6.1 Celgene Details
2.6.2 Celgene Major Business
2.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.6.4 Celgene Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Celgene Recent Developments and Future Plans
2.7 Daiichi Sankyo
2.7.1 Daiichi Sankyo Details
2.7.2 Daiichi Sankyo Major Business
2.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.7.4 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Daiichi Sankyo Recent Developments and Future Plans
2.8 Philogen S.p.A.
2.8.1 Philogen S.p.A. Details
2.8.2 Philogen S.p.A. Major Business
2.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.8.4 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Philogen S.p.A. Recent Developments and Future Plans
2.9 Tesaro
2.9.1 Tesaro Details
2.9.2 Tesaro Major Business
2.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.9.4 Tesaro Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Tesaro Recent Developments and Future Plans
2.10 Tragara/Adastra
2.10.1 Tragara/Adastra Details
2.10.2 Tragara/Adastra Major Business
2.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.10.4 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Tragara/Adastra Recent Developments and Future Plans
2.11 Tocagen
2.11.1 Tocagen Details
2.11.2 Tocagen Major Business
2.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Product and Solutions
2.11.4 Tocagen Isocitrate Dehydrogenase Inhibitors Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Tocagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Isocitrate Dehydrogenase Inhibitors Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Isocitrate Dehydrogenase Inhibitors Players Market Share
3.2.2 Top 10 Isocitrate Dehydrogenase Inhibitors Players Market Share
3.2.3 Market Competition Trend
3.3 Isocitrate Dehydrogenase Inhibitors Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Isocitrate Dehydrogenase Inhibitors Revenue and Market Share by Type (2016-2021)
4.2 Global Isocitrate Dehydrogenase Inhibitors Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Application (2016-2021)
5.2 Isocitrate Dehydrogenase Inhibitors Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2026)
6.2 North America Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2026)
6.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Country
6.3.1 North America Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2026)
6.3.2 United States Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
6.3.3 Canada Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
6.3.4 Mexico Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2026)
7.2 Europe Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2026)
7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Country
7.3.1 Europe Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2026)
7.3.2 Germany Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
7.3.3 France Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
7.3.5 Russia Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
7.3.6 Italy Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2026)
8.2 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2026)
8.3 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Market Size by Region
8.3.1 Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Region (2016-2026)
8.3.2 China Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
8.3.3 Japan Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
8.3.4 South Korea Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
8.3.5 India Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
8.3.7 Australia Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2026)
9.2 South America Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2026)
9.3 South America Isocitrate Dehydrogenase Inhibitors Market Size by Country
9.3.1 South America Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2026)
9.3.2 Brazil Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
9.3.3 Argentina Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2026)
10.2 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2026)
10.3 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Market Size by Country
10.3.1 Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2026)
10.3.2 Turkey Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
10.3.4 UAE Isocitrate Dehydrogenase Inhibitors Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Isocitrate Dehydrogenase Inhibitors Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Isocitrate Dehydrogenase Inhibitors Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Isocitrate Dehydrogenase Inhibitors Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) by Region (2016-2021)
Table 5. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Region (2021-2026)
Table 6. AGIOS Corporate Information, Head Office, and Major Competitors
Table 7. AGIOS Major Business
Table 8. AGIOS Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 9. AGIOS Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Aslan Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 11. Aslan Pharmaceuticals Major Business
Table 12. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 13. Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 17. Bayer Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beigene Corporate Information, Head Office, and Major Competitors
Table 19. Beigene Major Business
Table 20. Beigene Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 21. Beigene Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors
Table 23. Bristol-Myers Squibb Major Business
Table 24. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 25. Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Celgene Corporate Information, Head Office, and Major Competitors
Table 27. Celgene Major Business
Table 28. Celgene Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 29. Celgene Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Daiichi Sankyo Corporate Information, Head Office, and Major Competitors
Table 31. Daiichi Sankyo Major Business
Table 32. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 33. Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Philogen S.p.A. Corporate Information, Head Office, and Major Competitors
Table 35. Philogen S.p.A. Major Business
Table 36. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 37. Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Tesaro Corporate Information, Head Office, and Major Competitors
Table 39. Tesaro Major Business
Table 40. Tesaro Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 41. Tesaro Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Tragara/Adastra Corporate Information, Head Office, and Major Competitors
Table 43. Tragara/Adastra Major Business
Table 44. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 45. Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Tocagen Corporate Information, Head Office, and Major Competitors
Table 47. Tocagen Major Business
Table 48. Tocagen Isocitrate Dehydrogenase Inhibitors Product and Solutions
Table 49. Tocagen Isocitrate Dehydrogenase Inhibitors Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) by Players (2019-2021)
Table 51. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Players (2019-2021)
Table 52. Breakdown of Isocitrate Dehydrogenase Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. Isocitrate Dehydrogenase Inhibitors Players Head Office, Products and Services Provided
Table 54. Isocitrate Dehydrogenase Inhibitors Mergers & Acquisitions in the Past Five Years
Table 55. Isocitrate Dehydrogenase Inhibitors New Entrants and Expansion Plans
Table 56. Global Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) by Type (2016-2021)
Table 57. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Type (2016-2021)
Table 58. Global Isocitrate Dehydrogenase Inhibitors Revenue Forecast by Type (2021-2026)
Table 59. Global Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2021)
Table 60. Global Isocitrate Dehydrogenase Inhibitors Revenue Forecast by Application (2021-2026)
Table 61. North America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 62. North America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 63. North America Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 64. North America Isocitrate Dehydrogenase Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 65. North America Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 66. North America Isocitrate Dehydrogenase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe Isocitrate Dehydrogenase Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe Isocitrate Dehydrogenase Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe Isocitrate Dehydrogenase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue by Region (2021-2026) & (USD Million)
Table 79. South America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 80. South America Isocitrate Dehydrogenase Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 81. South America Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 82. South America Isocitrate Dehydrogenase Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 83. South America Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 84. South America Isocitrate Dehydrogenase Inhibitors Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa Isocitrate Dehydrogenase Inhibitors Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Isocitrate Dehydrogenase Inhibitors Picture
Figure 2. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type in 2020
Figure 3. IDH1 Mutant Medullary Malignant Tumor
Figure 4. IDH2 Mutant Medullary Malignant Tumor
Figure 5. Others
Figure 6. Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Application in 2020
Figure 7. DH Inhibitor Picture
Figure 8. FLT3 Inhibitor Picture
Figure 9. Hedgehog Pathway Inhibitor Picture
Figure 10. Others Picture
Figure 11. Global Isocitrate Dehydrogenase Inhibitors Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Isocitrate Dehydrogenase Inhibitors Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Region (2016-2026)
Figure 14. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Region in 2020
Figure 15. North America Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Isocitrate Dehydrogenase Inhibitors Market Drivers
Figure 21. Isocitrate Dehydrogenase Inhibitors Market Restraints
Figure 22. Isocitrate Dehydrogenase Inhibitors Market Trends
Figure 23. AGIOS Recent Developments and Future Plans
Figure 24. Aslan Pharmaceuticals Recent Developments and Future Plans
Figure 25. Bayer Recent Developments and Future Plans
Figure 26. Beigene Recent Developments and Future Plans
Figure 27. Bristol-Myers Squibb Recent Developments and Future Plans
Figure 28. Celgene Recent Developments and Future Plans
Figure 29. Daiichi Sankyo Recent Developments and Future Plans
Figure 30. Philogen S.p.A. Recent Developments and Future Plans
Figure 31. Tesaro Recent Developments and Future Plans
Figure 32. Tragara/Adastra Recent Developments and Future Plans
Figure 33. Tocagen Recent Developments and Future Plans
Figure 34. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Players in 2020
Figure 35. Isocitrate Dehydrogenase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Isocitrate Dehydrogenase Inhibitors Revenue Market Share in 2020
Figure 37. Global Top 10 Players Isocitrate Dehydrogenase Inhibitors Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Type in 2020
Figure 40. Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Type (2021-2026)
Figure 41. Global Isocitrate Dehydrogenase Inhibitors Revenue Share by Application in 2020
Figure 42. Global Isocitrate Dehydrogenase Inhibitors Market Share Forecast by Application (2021-2026)
Figure 43. North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type (2016-2026)
Figure 44. North America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2016-2026)
Figure 45. North America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 46. United States Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type (2016-2026)
Figure 50. Europe Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2016-2026)
Figure 51. Europe Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 52. Germany Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Region (2016-2026)
Figure 60. China Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type (2016-2026)
Figure 67. South America Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2016-2026)
Figure 68. South America Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Isocitrate Dehydrogenase Inhibitors Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Isocitrate Dehydrogenase Inhibitors Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source
